Evidence map›Paper›PMID 34452356›Full record

ArticleViruses2021

Rise and Fall of SARS-CoV-2 Lineage A.27 in Germany.

Sébastien Calvignac-Spencer, Matthias Budt, Matthew Huska, Hugues Richard, Luca Leipold, Linus Grabenhenrich, Torsten Semmler, Max von Kleist, Stefan Kröger, Thorsten Wolff and 1 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Spike protein of SARS-CoV-2 variants: a brief review and practical implications.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  2. Advancing Precision Vaccinology by Molecular and Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 in Germany, 2021.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sébastien Calvignac-SpencerEpidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0003-4834-0509
Matthias BudtInfluenza and other Respiratory Viruses, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0001-5960-515X
Matthew HuskaMethodology and Research Infrastructure, Bioinformatics, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0002-0912-745X
Hugues RichardMethodology and Research Infrastructure, Bioinformatics, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0001-7776-1340
Luca LeipoldMethodology and Research Infrastructure, Information and Research Data Management, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0003-1351-1240
Linus GrabenhenrichMethodology and Research Infrastructure, Information and Research Data Management, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0002-9300-6625
Torsten SemmlerMethodology and Research Infrastructure, Genome Sequencing and Genomic Epidemiology, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0002-2225-7267
Max von KleistSystems Medicine of Infectious Disease, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0001-6587-6394
Stefan KrögerInfectious Disease Epidemiology, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0002-9457-4798
Thorsten WolffInfluenza and other Respiratory Viruses, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0001-7688-236X
Martin HölzerMethodology and Research Infrastructure, Bioinformatics, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0001-7090-8717
Robert Koch Institute · DE

Funding

Bundesministerium fuer Gesundheit DESHBundesministerium für Bildung und Forschung 01KI2016Bundesministerium für Bildung und Forschung 031L0176AJoachim Herz Stiftung Add-on fellowship for interdisciplinary life science
6 · The paper itself

Abstract

Here, we report on the increasing frequency of the SARS-CoV-2 lineage A.27 in Germany during the first months of 2021. Genomic surveillance identified 710 A.27 genomes in Germany as of 2 May 2021, with a vast majority identified in laboratories from a single German state (Baden-Wuerttemberg,

Indexed as

Amino Acid SubstitutionCOVID-19FranceGenome, ViralGermanyHumansMutationPhylogenySARS-CoV-2Spike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusmolecular sequence datapublic health surveillanceSARS-CoV-2 variantsviral genomes

Identifiers

PMID34452356
PMCPMC8402818
OpenAlexW3190214806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.